STANFORD, Calif. - Taking advantage of the open-air laboratory that is San Francisco, Peter Small, MD, has collected samples of virtually every case of tuberculosis that has occurred in the city for the last 13 years - almost 3,000 total. In this week's advance online edition of The Proceedings of the National Academy of Sciences, the associate professor of infectious diseases and geographic medicine at the Stanford University School of Medicine and his colleagues present a genetic analysis of 100 of these samples. The findings suggest ways the bacteria can escape a host's immune system or develop antibiotic resistance.
The team took its analysis a step further in a second paper, which appears in the same edition of the journal. They found that people from different regions of the world carry different strains of the tuberculosis bacteria, pointing out the importance of sociological interactions in infectious disease transmission. This also raises the possibility that the pathogen evolves within a geographic population group and doesn't spread to other groups.
"It was remarkable how well the genetics mapped to global geography," said Small. "Co-evolution is highly speculative, but it's an intriguing possibility. Most importantly, it's a hypotheses we now have the technology to address."
Tuberculosis causes more adult deaths than any other infectious disease. Worldwide, one person in three is infected, but it remains a problem primarily in the developing world. However, the emergence of tuberculosis strains resistant to multiple drugs in industrialized countries is prompting renewed interest in vaccination.
There has long been anecdotal evidence that tuberculosis bacteria differ throughout the world, said Small, who is currently on leave from Stanford serving as a senior program officer in the Global Health Program of the Bill and Melinda Gates Foundation. Additionally, he said, studies testing tuberculosis vaccines have varied widely Page: 1 2 3 Related medicine news :1
Contact: Mitzi Baker
Stanford University Medical Center
. Tuberculosis drug combined with virtual reality therapy is effective in treating fear of heights2
. UCSD Medical Center receives NIH contract to set up National Tuberculosis Educational Curriculum3
. Tuberculosis Foundation selects Core Research Scientists4
. New quick test for drug-resistant strains of gonorrhea5
. Nabi StaphVAX elicits antibodies with in vitro activity against antibiotic-resistant Staphylococcus aureus strains6
. War on bacteria could leave drug-resistant strains unchecked7
. New data provide further evidence of effectiveness of targeted delivery of Relenza and efficacy in both A&B strains8
. Indiana University researchers closer to helping hearing-impaired using stem cells9
. Chemicals in tattoo inks need closer scrutiny10
. Researchers close in on breast cancer vaccine11
. Drug companies should disclose adverse events before licensing